Imatinib
What's New
Last Posted: Sep 28, 2020
- Cost-effectiveness Analysis of Genetic Testing and Tailored First-Line Therapy for Patients With Metastatic Gastrointestinal Stromal Tumors
S Banerjee et al, JAMA Network Open, September 28, 2020 - Understanding Precision Medicine And AI Within The Life Cycle Of Technology Revolutions
D Shaywitz, Forbes, October 16, 2019 - Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine.
Groenland Stefanie L et al. European journal of clinical pharmacology 2019 Jun - Future of Evidence Synthesis in Precision Oncology: Between Systematic Reviews and Biocuration
SM Boca et al, JCO Precision Oncology, September 2018 - Identification of Prognostic and Susceptibility Markers in Chronic Myeloid Leukemia Using Next Generation Sequencing.
Shokeen Yogender et al. Ethiopian journal of health sciences 2018 Mar 28(2) 135-146 - The emerging potential for network analysis to inform precision cancer medicine.
Ozturk Kivilcim et al. Journal of molecular biology 2018 Jun - Drugs OKd To Hit Tumor Genes Still a Basket of One. Are More Coming
A Lash, Xconomy, June 2018 - Pharmacogenetics and the treatment of chronic myeloid leukemia: how relevant clinically? An update.
Ankathil Ravindran et al. Pharmacogenomics 2018 Mar - Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: a systematic review and meta-analysis.
Cargnin Sarah et al. Pharmacological research 2018 Feb - TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome.
Weich Natalia et al. Blood cells, molecules & diseases 2016 Jul 59129-33
More
About PGx PHGKB
PGx PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to medications....more
Content Summary
Common PGx Related Topics
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 26, 2021
- Content source: